Literature DB >> 3307786

Ten to fourteen residue peptides of Alzheimer's disease protein are sufficient for amyloid fibril formation and its characteristic x-ray diffraction pattern.

P D Gorevic, E M Castano, R Sarma, B Frangione.   

Abstract

The molecular basis of fibril formation in Alzheimers disease was explored by electron micrographic and x-ray diffraction analysis of a series of synthetic peptides corresponding to portions of the amino acid sequence of beta protein and that of its putative precursor. A minimum 14 residue peptide was identified that formed typical amyloid fibrils under physiological conditions. Of these 14 residues, 10 were sufficient to give an identical 4.76 A and 10.6 A diffraction pattern as that recently described for isolated neurofibrillary tangles, amyloid plaque cores and leptomeningeal amyloid fibrils.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3307786     DOI: 10.1016/0006-291x(87)91008-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

1.  Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis.

Authors:  W Sue T Griffin; Steven W Barger
Journal:  US Neurol       Date:  2010

2.  Epitope map of two polyclonal antibodies that recognize amyloid lesions in patients with Alzheimer's disease.

Authors:  J Ghiso; T Wisniewski; R Vidal; A Rostagno; B Frangione
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

3.  Different configurational states of beta-amyloid and their distributions relative to plaques and tangles in Alzheimer disease.

Authors:  M G Spillantini; M Goedert; R Jakes; A Klug
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

4.  On the nucleation of amyloid beta-protein monomer folding.

Authors:  Noel D Lazo; Marianne A Grant; Margaret C Condron; Alan C Rigby; David B Teplow
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

5.  Beta-amyloid peptide blocks the fast-inactivating K+ current in rat hippocampal neurons.

Authors:  T A Good; D O Smith; R M Murphy
Journal:  Biophys J       Date:  1996-01       Impact factor: 4.033

6.  Lipid-induced conformational transition of amyloid beta peptide fragments.

Authors:  Nagarajan Sureshbabu; R Kirubagaran; H Thangarajah; E J Padma Malar; R Jayakumar
Journal:  J Mol Neurosci       Date:  2010-05-18       Impact factor: 3.444

7.  A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice.

Authors:  Marcin Sadowski; Joanna Pankiewicz; Henrieta Scholtzova; James A Ripellino; Yongsheng Li; Stephen D Schmidt; Paul M Mathews; John D Fryer; David M Holtzman; Einar M Sigurdsson; Thomas Wisniewski
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

8.  Synthetic peptides homologous to prion protein residues 106-147 form amyloid-like fibrils in vitro.

Authors:  F Tagliavini; F Prelli; L Verga; G Giaccone; R Sarma; P Gorevic; B Ghetti; F Passerini; E Ghibaudi; G Forloni
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

9.  The cerebrospinal-fluid soluble form of Alzheimer's amyloid beta is complexed to SP-40,40 (apolipoprotein J), an inhibitor of the complement membrane-attack complex.

Authors:  J Ghiso; E Matsubara; A Koudinov; N H Choi-Miura; M Tomita; T Wisniewski; B Frangione
Journal:  Biochem J       Date:  1993-07-01       Impact factor: 3.857

Review 10.  Polymorphism in Alzheimer Abeta amyloid organization reflects conformational selection in a rugged energy landscape.

Authors:  Yifat Miller; Buyong Ma; Ruth Nussinov
Journal:  Chem Rev       Date:  2010-08-11       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.